Davion Healthcare PLC (DAVI) shareholders
Close on Nov 18, 2026Market cap –P/E –Yield –
Ownership
Who owns Davion Healthcare's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jack Harry Kaye | 10,268,948 | 41.08% | 13D (active) amendment | Aug 11, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jack Harry Kaye | CHIEF EXECUTIVE OFFICER, Director, 10% owner | 10,268,948 | 41.08% | Apr 17, 2026 |
| Julian Sluyters | Director | 30,000 | 0.12% | Nov 17, 2026 |
| Susan M. King | Director | 15,000 | 0.06% | Nov 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Susan M. King Director | Nov 17, 2026 | Buy | +10,000 | $0.10 | $980 | 15,000 |
| Julian Sluyters Director | Nov 16, 2026 | Buy | +25,000 | $1.06 | $26.49K | 30,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Davion Healthcare's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?